• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, February 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Klebsiella pneumoniae drug resistance in infants studied in Kazan

Bioengineer by Bioengineer
October 10, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The research was conducted by Kazan Federal University, Kazan State Medical University, City Clinical Children's Hospital N 1, and Republican Clinical Infectious Diseases Hospital.

K. pneumoniae is known to cause a number of infectious diseases of lungs, kidneys, intestines, liver, and blood. It has become widely known in recent years because of quickly growing drug resistance backed by the production of extended-spectrum beta lactamases (ESBLs).

To study its virulence factors, a strain was extracted from the blood of neonates with sepsis and compared with strains from those with urinary tract infections.

In neonates with sepsis testing of K. pneumoniae isolates for ESBL production was positive in 60% of cases, in neonates with UTI–in 40% of cases. The authors commented that one of key virulence factors – the rmpA gene – was found in both groups of infants. This means the prevalence of virulent K. pneumoniae strains is higher than was previously thought, and heavier clinical forms of diseases were found in patients with those virulent strains.

###

Media Contact

Yury Nurmeev
[email protected]
@KazanUni

http://kpfu.ru/eng

https://kpfu.ru/eng/news-eng/klebsiella-pneumoniae-drug-resistance-in-infants.html

Related Journal Article

http://dx.doi.org/10.3389/fmed.2018.00225

Share12Tweet8Share2ShareShareShare2

Related Posts

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

February 9, 2026

Exercise’s Impact on SASP Biomarkers in Seniors Unexplored

February 9, 2026

UK’s Rising Synthetic Opioid Crisis: Nitazene-Linked Deaths May Be Underreported by Up to 33%

February 9, 2026

Evaluating Digital Diabetes Screening’s B2C Potential in Switzerland

February 8, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Mapping Tertiary Lymphoid Structures for Kidney Cancer Biomarkers

    50 shares
    Share 20 Tweet 13
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Intensive Short-Duration Exercise Outperforms Standard Care in Treating Panic Disorder

Exercise’s Impact on SASP Biomarkers in Seniors Unexplored

UK’s Rising Synthetic Opioid Crisis: Nitazene-Linked Deaths May Be Underreported by Up to 33%

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 74 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.